Innovative Peptide Complexes Featured at CPhI Worldwide 2017

Contents

Innovative Peptide Complexes Featured at CPhI Worldwide 2017
CPhI Exhibition Outcomes in Frankfurt

Send on email

Published on October 26, 2017, IDEAL PHARMA PEPTIDE, in collaboration with Wuxi Jinghai Amino Acid, is set to showcase their latest innovative peptide complexes at the CPhI Worldwide 2017 exhibition. This significant pharmaceutical event will take place from October 24 to 26, 2017, in Frankfurt am Main, Germany, where IDEAL PHARMA PEPTIDE will present its groundbreaking IPH amino acid-peptide complexes, developed in partnership with Wuxi Jinghai Amino Acid Co Ltd, at booth 10.1F50.

The decision for IDEAL PHARMA PEPTIDE (Germany) to partner with Wuxi Jinghai Amino Acid (China) was strategic. Established in 1993, the latter has grown to become one of China’s leading amino acid manufacturers with the right to export and import relevant products and raw materials. The company has been certified with GMP, HALAL, KOSHER, ISO 9001, and ISO 22000 since 2002.

Wuxi Jinghai Amino Acid Co Ltd (WJAA) is a key player in China’s national development plan and a high-tech enterprise in Jiangsu province, where it is located. Furthermore, WJAA is a member of the China Pharmaceutical Industry Association. The company employs 250 staff members and operates over a 38,388 sq. m area, with 16,762 sq. m dedicated to manufacturing facilities. WJAA produces approximately 3,000 metric tons of amino acids annually, utilizing cutting-edge equipment, technology, and a highly skilled workforce. Their primary amino acid brand is AMINOWILL.

These factors were crucial in the decision to collaborate with WJAA for the production of IPH peptide complexes like BCAA IPH AGAA, BCAA IPH AVN, and BCAA IPH AEN, employing IDEAL PHARMA PEPTIDE (GERMANY) technologies and short peptides, based on high-quality AMINOWILL amino acids. The products are aimed at European and American companies that specialize in innovative solutions for sports nutrition manufacturing.

CPhI Exhibition Outcomes in Frankfurt

Published on October 30, 2017, following the October CPhI exhibition in Frankfurt, Ideal Pharma Peptid GmbH successfully entered into agreements with the Chinese company Fingres Ingredients, Quality & Technology for collaboration and distribution of IPH amino acid peptide complexes in Southeast Asia. Additionally, a contract was signed at the exhibition for the development of a new product, Omega 7.

Agreements were also reached for cooperation with the South Korean company Kor-AsianHealthcarePvt. Co., which specializes in high-quality dietary supplements.